CClinicalTrials.gg
Sign In
TerminatedNCT01506674Updated Jan 18, 2024

Metabolomic in Critical Ill Patients

An observational study in Metabolomic, sponsored by Università Vita-Salute San Raffaele. Terminated at 1 site in Italy. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-01-18.

Sponsored by Università Vita-Salute San Raffaele · Observational

Why this study was terminated
The study was terminated prematurely due to slow recruitment.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
94
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.

02

Conditions studied

  • Metabolomic
03

In context

Lead sponsor

Università Vita-Salute San Raffaele is the lead sponsor of 84 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Critical ill patients

Inclusion criteria

  • patients with severe left or right ventricular dysfunction undergoing cardiac surgery
  • patients undergoing ablation of ventricular tachycardia
  • patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases
  • patients undergoing thoracoabdominal vascular surgery

Exclusion criteria

Exclusion Criteria:

  • pregnant women
  • no written consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
94 participants (actual)

Groups and cohorts

  • criticall ill patients
06

What researchers measure

Primary outcomes

  1. Metabolomic patterns to identify poor outcome

    Time frame: hospital stay (approximately two weeks)

07

Study locations

1 site
  • Università Vita-Salute San Raffaele
    Milano, Mi 20132, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01506674
Lead sponsor
Università Vita-Salute San Raffaele
Responsible party
Giovanni Landoni (MD, Associate Professor, Università Vita-Salute San Raffaele) — Principal investigator
First posted
Jan 10, 2012
Start date
Jan 27, 2015
Primary completion
Oct 31, 2017
Completion
Apr 6, 2023
Last update
Jan 18, 2024
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Università Vita-Salute San Raffaele

Start the discussion